Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (211-220 of 460) with videos related to

Pageof 46
Sort By:
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Blood|March 6, 2014
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cellsSaar Gill, Sarah K Tasian, Marco Ruella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastomaStephan A Grupp, Eline Luning Prak, Jean Boyer, et al.
Cancer Research|October 8, 2010
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumorYangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2016
Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial InfectionsDonald T Gracias, Alina C Boesteanu, Joseph A Fraietta, et al.
Immunologic Research|October 9, 2008
Genetic engineering of T cells for adoptive immunotherapyAngel Varela-Rohena, Carmine Carpenito, Elena E Perez, et al.
Cancer Research|November 4, 2024
Editor's Note: Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated TumorYangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Immunity|November 22, 2025
IL-9 signaling redirects CAR T cell fate toward CD8<sup>+</sup> memory and CD4<sup>+</sup> cycling states, enhancing antitumor efficacySofía Castelli, Wesley V Wilson, Ugur Uslu, et al.
Advanced Healthcare Materials|August 21, 2023
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell EngineeringAlex G Hamilton, Kelsey L Swingle, Ryann A Joseph, et al.
Cancer Biology & Therapy|November 14, 2003
Tumor expression of 4-1BB ligand sustains tumor lytic T cellsHua Zhang, Melinda S Merchant, Kevin S Chua, et al.
Pageof 46

Showing results (211-220 of 460) with videos related to

Sort By:
Pageof 46
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Blood|March 6, 2014
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cellsSaar Gill, Sarah K Tasian, Marco Ruella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastomaStephan A Grupp, Eline Luning Prak, Jean Boyer, et al.
Cancer Research|October 8, 2010
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumorYangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2016
Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial InfectionsDonald T Gracias, Alina C Boesteanu, Joseph A Fraietta, et al.
Immunologic Research|October 9, 2008
Genetic engineering of T cells for adoptive immunotherapyAngel Varela-Rohena, Carmine Carpenito, Elena E Perez, et al.
Cancer Research|November 4, 2024
Editor's Note: Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated TumorYangbing Zhao, Edmund Moon, Carmine Carpenito, et al.
Immunity|November 22, 2025
IL-9 signaling redirects CAR T cell fate toward CD8<sup>+</sup> memory and CD4<sup>+</sup> cycling states, enhancing antitumor efficacySofía Castelli, Wesley V Wilson, Ugur Uslu, et al.
Advanced Healthcare Materials|August 21, 2023
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell EngineeringAlex G Hamilton, Kelsey L Swingle, Ryann A Joseph, et al.
Cancer Biology & Therapy|November 14, 2003
Tumor expression of 4-1BB ligand sustains tumor lytic T cellsHua Zhang, Melinda S Merchant, Kevin S Chua, et al.
Pageof 46